The Clorox Company (NYSE:CLX) Shares Sold by Swiss National Bank

Swiss National Bank lowered its stake in The Clorox Company (NYSE:CLX) by 5.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 349,300 shares of the company’s stock after selling 19,300 shares during the quarter. Swiss National Bank owned about 0.28% of Clorox worth $56,730,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CLX. Integral Investment Advisors Inc. raised its position in shares of Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after buying an additional 67 shares in the last quarter. HCR Wealth Advisors increased its stake in shares of Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after acquiring an additional 68 shares during the period. Sound View Wealth Advisors Group LLC raised its holdings in Clorox by 6.1% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock worth $218,000 after purchasing an additional 77 shares in the last quarter. Empower Advisory Group LLC lifted its position in Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after purchasing an additional 78 shares during the period. Finally, Aviance Capital Partners LLC boosted its stake in Clorox by 2.7% during the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after purchasing an additional 80 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.3 %

Shares of NYSE CLX opened at $147.32 on Friday. The stock has a market cap of $18.15 billion, a price-to-earnings ratio of 40.25, a PEG ratio of 2.62 and a beta of 0.45. The business has a 50 day simple moving average of $154.20 and a 200 day simple moving average of $160.20. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business earned $2.16 EPS. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.31%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Evercore ISI boosted their price objective on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Barclays lifted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Finally, Wells Fargo & Company lifted their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.